ATPases as drug targets: Learning from their structure

Nature Reviews Drug Discovery

Volumn 1, Issue 9, 2002, Pages 665-673

  Chène, Patrick ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

17 ALLYLAMINOGELDANAMYCIN; 2,3 BIS(3,5 DIOXO 1 PIPERAZINYL)BUTANE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE INHIBITOR; ANSAMYCIN DERIVATIVE; BAFILOMYCIN; BENZIMIDAZOLE; DIGOXIN; DNA TOPOISOMERASE (ATP HYDROLYSING); GELDANAMYCIN; GLYCOPROTEIN P; GR 122222X; GYRASE INHIBITOR; HEAT SHOCK PROTEIN 90; IMATINIB; INDAZOLE DERIVATIVE; KINESIN; MONASTROL; MUSCLE RELAXANT AGENT; MYOSIN; NOVOBIOCIN; OMEPRAZOLE; PROTEIN KINASE INHIBITOR; PU 3; PYRROLOPYRIMIDINE DERIVATIVE; RADICICOL; SULFONAMIDE; TARIQUIDAR; UNCLASSIFIED DRUG; UNINDEXED DRUG; ENZYME INHIBITOR;

ANTINEOPLASTIC ACTIVITY; CELL FUNCTION; CLINICAL TRIAL; COMPETITIVE INHIBITION; DRUG BINDING; DRUG DESIGN; DRUG MARKETING; DRUG MECHANISM; DRUG RESEARCH; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; HUMAN; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS; CHEMISTRY; DRUG ANTAGONISM; DRUG INTERACTION; METABOLISM; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION;

ADENOSINE TRIPHOSPHATASES; DRUG DESIGN; DRUG INTERACTIONS; ENZYME INHIBITORS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036718795     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd894     Document Type: Review

References (90)

1. Csermely, P., Schnaider, T., Soti, C., Prohaszka, Z. & Nardai, G. The 90-kDa molecular chaperone family: structure, function and clinical applications. A comprehensive review. Pharmacol. Ther. 79, 129-168 (1998).
2. Ranson, N. A., White, H. E. & Saibil, H. R. Chaperonins. Biochem. J. 333, 233-242 (1998).
3. Hirokawa, N., Noda, Y. & Okada, Y. Kinesin and dynein superfamily proteins in organelle transport and cell division. Curr. Opin. Cell Biol. 10, 60-73 (1998).
4. Langer, T. AAA proteases: cellular machines for degrading membrane proteins. Trends Biochem. Sci. 25, 247-251 (2000).
5. Lee, D. G. & Bell, S. P. ATPase switches controlling DNA replication initiation. Curr. Opin. Cell Biol. 12, 280-285 (2000).
6. Yang, W. Structure and function of mismatch repair proteins. Mutat. Res. 460, 245-256 (2000).
7. Caruthers, J. M. & McKay, D. B. Helicase structure and mechanism. Curr. Opin. Struct. Biol. 12, 123-133 (2002).
8. +)-ATPases - nature's most versatile proton pumps. Nature Rev. Mol. Cell Biol. 3, 94-103 (2002).
9. + lymphocytes after oral and intravenous administration. Clin. Cancer Res. 6, 4186-4191 (2000).
10. Wood, M. A., McMahon, S. B. & Cole, M. D. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-myc. Mol. Cell 5, 321-330 (2000).
11. Yeo, H. J., Savvides, S. N., Herr, A. B., Lanka, E. & Waksman, G. Crystal structure of the hexameric traffic ATPase of the Helicobacter pylori type IV secretion system. Mol. Cell 6, 1461-1472 (2000).
12. Cohen, P. Protein kinases - the major drug targets of the twenty-first century? Nature Rev. Drug Discov. 1, 309-315 (2002).
13. Scapin, G. Structural biology in drug design: selective protein kinase inhibitors. Drug Discov. Today 7, 601-611 (2002).
14. Al-Obeidi, F. A. & Lam, K. S. Development of inhibitors for tyrosine kinases. Oncogene 19, 5690-5701 (2000).
15. Traxler, P. et al. Tyrosine kinase inhibitors: from rational design to clinical trials. Med. Res. Rev. 21, 499-512 (2001).
16. Xu, H., Niedenzu, T & Saenger, W. DNA helicase RepA: cooperative ATPase activity and binding of nucleotides. Biochemistry 39, 12225-12233 (2000).
17. Traxler, P. & Furet, P. Strategies toward the design of novel and selective protein tyrosine kinase inhibitors. Pharmacol. Ther. 82, 195-206 (1999).
18. Rossmann, M. G., Moras, D. & Olsen, K. W. Chemical and biological evolution of nucleotide-binding protein. Nature 250, 194-199 (1974).
19. Walker, J. E., Saraste, M., Runswick, M. J. & Gay, N. J. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J. 1, 945-951 (1982).
20. Saraste, M., Sibbald, P. R. & Wittinghofer, A. The P-loop - a common motif in ATP- and GTP-binding proteins. Trends Biochem. Sci. 15, 430-434 (1990).
21. Schulz, G. E. Binding of nucleotides by proteins. Curr. Biol. 2, 61-67 (1992).
22. Bossemeyer, D. The glycine-rich sequence of protein kinases: a multifunctional element. Trends Biochem. Sci. 19, 201-205 (1994).
23. Vetter, I. R. & Wittinghofer, A. Nucleoside triphosphate-binding proteins: different scaffolds to achieve phosphoryl transfer. Quart. Rev. Biophys. 32, 1-56 (1999).
24. Mushegian, A. R., Bassett, D. E., Jr, Boguski, M. S., Bork, P. & Koonin, E. V. Positionally cloned human disease genes: patterns of evolutionary conservation and functional motifs. Proc. Natl Acad. Sci. USA 94, 5831-5836 (1997).
25. Ban, C. & Yang, W. Crystal structure and ATPase activity of MutL: implications for DNA repair and mutagenesis. Cell 95, 541-552 (1998).
26. Guarne, A., Junop, M. S. & Yang, W. Structure and function of the N-terminal 40 kDa fragment of human PMS2: a monomeric GHL ATPase. EMBO J. 20, 5521-5531 (2001).
27. Bork, P., Sander, C. & Valencia, A. An ATPase domain common to prokaryotic cell cycle proteins, sugar kinases, actin, and Hsp70 heat shock proteins. Proc. Natl Acad. Sci. USA 89, 7290-7294 (1992).
28. Flaherty, K. M., McKay, D. B., Kabsch, W. & Holmes, K. C. Similarity of the three-dimensional structures of actin and the ATPase fragment of a 70-kDa heat shock cognate protein. Proc. Natl Acad. Sci. USA 88, 5041-5045 (1991).
29. Bochtler, M. et al. The structures of HsIU and the ATP-dependent protease HsIU-HsIV Nature 403, 800-805 (2000).
30. Trame, C. B. & McKay, D. B. Structure of Haemophilus influenzae HsIU protein in crystals with one-dimensional disorder twinning. Acta Crystallogr. D 57, 1079-1090 (2001).
31. Olson, W. K. & Sussman, J. L. How flexible is the furanose ring? 1. A comparison of experimental and theoretical studies. J. Am. Chem. Soc. 104, 270-278 (1982).
32. Moodie, S. L. & Thornton, J. M. A study into the effects of protein binding on nucleotide conformation. Nucleic Acids Res. 21, 1369-1380 (1993).
33. Fersht, A. Enzyme Structure and Mechanism 2nd edn (W. H. Freeman & Co., New York, 1985).
34. Moodie, S. L., Mitchell, J. B. & Thornton, J. M. Protein recognition of adenylate: an example of a fuzzy recognition template. J. Mol. Biol. 263, 486-500 (1996).
35. Zhao, S., Morris, G. M., Olson, A. J. & Goodsell, D. S. Recognition templates for predicting adenylate-binding sites in proteins. J. Mol. Biol. 314, 1245-1255 (2001).
36. Denessiouk, K. A. & Johnson, M. S. When fold is not important: a common structural framework for adenine and AMP binding in 12 unrelated protein families. Proteins 38, 310-326 (2000).
37. Roe, S. M. et al. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J. Med. Chem. 42, 260-266 (1999).
38. Blagosklonny, M. V. Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs. Leukemia 16, 455-462 (2002).
39. Grenert, J. P. et al. The amino-terminal domain of heat shock protein 90 (Hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates Hsp90 conformation. J. Biol. Chem. 272, 23843-23850 (1997).
40. Stebbins, C. E. et al. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell 89, 239-250 (1997).
41. Prodromou, C. et al. Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell 90, 65-75 (1997).
42. Neckers, L. Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol. Med. 8, S55-S61 (2002).
43. Piper, P. W. The Hsp90 chaperone as a promising drug target. Curr. Opin. Investig. Drugs 2, 1606-1610 (2001).
44. Besant, P. G, Lasker, M. V., Bui, C. D. & Turck. C. W. Inhibition of branched-chain α-keto acid dehydrogenase kinase and Sln1 yeast histidine kinase by the antifungal antibiotic radicicol. Mol. Pharmacol. 62, 289-296 (2002).
45. Felts, S. J. et al. The Hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J. Biol. Chem, 275, 3305-3312 (2000).
46. Lucas, B., Rosen, N. & Chiosis, G. Facile synthesis of a library of 9-alkyl-8-benzyl-9H-purin-6-ylamine derivatives. J. Comb. Chem. 3, 518-520 (2001).
47. Chiosis, G. et al. A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells. Chem. Biol. 8, 289-299 (2001).
48. Gormley, N. A., Orphanides, G., Meyer, A., Cullis, P. M. & Maxwell, A. The interaction of coumarin antibiotics with fragments of DNA gyrase B protein. Biochemistry 35, 5083-5092 (1996).
49. Lewis, R. J. et al. The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography. EMBO J. 15, 1412-1420 (1996).
50. Kim, O. K., Ohemeng, K. & Barrett, J. F. Advances in DNA gyrase inhibitors. Expert Opin. Investig. Drugs 10, 199-212 (2001).
51. Oram, M. et al. Mode of action of GR122222X, a novel inhibitor of bacterial DNA gyrase. Antimicrob. Agents Chemother 40, 473-476 (1996).
52. Boehm, H. J. et al. Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. J. Med. Chem. 43, 2664-2674 (2000).
53. Hopkins, S. C., Vale, R. D. & Kuntz, I. D. Inhibitors of kinesin activity from structure-based computer screening. Biochemistry 39, 2805-2814 (2000).
54. Davies, S. P., Reddy, H., Caivano, M. & Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105 (2000).
55. Mayer, T. U. et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286, 971-974 (1999).
56. Cheung, A. et al. A small-molecule inhibitor of skeletal muscle myosin II. Nature Cell Biol. 4, 83-88 (2002).
57. Eichhorn, E. J. & Gheorghiade, M. Digoxin. Prog. Cardiovasc. Dis. 44, 251-266 (2002).
58. Martin, C. et al. The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein. Br. J. Pharmacol. 128, 403-411 (1999).
59. Horn, J. The proton-pump inhibitors: similarities and differences. Clin. Ther. 22, 266-280 (2000).
60. +-ATPase. Curr. Med. Chem. 6, 1197-1212 (1999).
61. Hu, T., Sage, H. & Hsieh, T S. ATPase domain of eukaryotic DNA topoisomerase II. Inhibition of ATPase activity by the anti-cancer drug bisdioxopiperazine and ATP/ADP-induced dimerization. J. Biol. Chem. 277, 5944-5951 (2002).
62. Gulick, A. M., Bauer, C. B., Thoden, J. B. & Payment, I. X-ray structures of the MgADP, MgATPγS, and MgAMPPNP complexes of the Dictyostelium discoideum myosin motor domain. Biochemistry 36, 11619-11628 (1997).
63. Turner, J. et al. Crystal structure of the mitotic spindle kinesin Eg5 reveals a novel conformation of the neck-linker J. Biol. Chem. 276, 25496-25502 (2001).
64. Kikkawa, M. et al. Switch-based mechanism of kinesin motors. Nature 411, 439-445 (2001).
65. Song, Y. H. et al. Structure of a fast kinesin: implications for ATPase mechanism and interactions with microtubules. EMBO J. 20, 6213-6225 (2001).
66. Kull, F. J., Sablin, E. P., Lau, R., Fletterick, R. J. & Vale, R. D. Crystal structure of the kinesin motor domain reveals a structural similarity to myosin. Nature 380, 550-555 (1996).
67. Sablin, E. P. et al. Direction determination in the minus-end-directed kinesin motor Ncd. Nature 395, 813-816 (1998).
68. Yun, M., Zhang, X., Park, C. G., Park, H. W. & Endow, S. A. A structural pathway for activation of the kinesin motor ATPase. EMBO J. 20, 2611-2618 (2001).
69. Hopfner, K. P. et al. Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily. Cell 101, 789-800 (2000).
70. Lamers, M. H. et al. The crystal structure of DNA mismatch repair protein MutS binding to a G x T mismatch. Nature 407, 711-717 (2000).
71. Yuan, Y. R. et al. The crystal structure of the MJ0796 ATP-binding cassette. Implications for the structural consequences of ATP hydrolysis in the active site of an ABC transporter. J. Biol. Chem. 276, 32313-32321 (2001).
72. Karpowich, N. et al. Crystal structures of the MJ1267 ATP binding cassette reveal an induced-fit effect at the ATPase active site of an ABC transporter. Structure 9, 571-586 (2001).
73. Gaudet, R. & Wiley, D. C. Structure of the ABC ATPase domain of human TAP1, the transporter associated with antigen processing. EMBO J. 20, 4964-4972 (2001).
74. Soultanas, P., Dillingham, M. S., Velankar, S. S. & Wigley, D. B. DNA binding mediates conformational changes and metal ion coordination in the active site of PcrA helicase. J. Mol. Biol. 290, 137-148 (1999).
75. Putnam, C. D. et al. Structure and mechanism of the RuvB Holliday junction branch migration motor. J. Mol. Biol. 311, 297-310 (2001).
76. Oyama, T., Ishino, Y., Cann, I. K., Ishino, S. & Morikawa, K. Atomic structure of the clamp loader small subunit from Pyrococcus furiosus. Mol. Cell 8, 455-463 (2001).
77. Lenzen, C. U., Steinmann, D., Whiteheart, S. W. & Weis, W. I. Crystal structure of the hexamerization domain of N-ethylmaleimide-sensitive fusion protein. Cell 94, 525-536 (1998).
78. Zhang, X. et al. Structure of the AAA ATPase p97. Mol. Cell 6, 1473-1484 (2000).
79. Liu, J. et al. Structure and function of Cdc6/Cdc18: implications for origin recognition and checkpoint control. Mol. Cell 6, 637-648 (2000).
80. Singleton, M. R., Sawaya, M. R., Ellenberger, T. & Wigley, D. B. Crystal structure of T7 gene 4 ring helicase indicates a mechanism for sequential hydrolysis of nucleotides. Cell 101, 589-600 (2000).
81. Menz, R. I., Walker, J. E. & Leslie, A. G. Structure of bovine mitochondrial F(1)-ATPase with nucleotide bound to all three catalytic sites: implications for the mechanism of rotary catalysis. Cell 106, 331-341 (2001).
82. Hayashi, I., Oyama, T. & Morikawa, K. Structural and functional studies of MinD ATPase: implications for the molecular recognition of the bacterial cell division apparatus. EMBO J. 20, 1819-1828 (2001).
83. Zhou, T., Radaev, S., Rosen, B. P. & Gatti, D. L. Conformational changes in four regions of the Escherichia coli ArsA ATPase link ATP hydrolysis to ion translocation. J. Biol. Chem. 276, 30414-30422 (2001).
84. Schutt, C. E., Myslik, J. C., Rozycki, M. D., Goonesekere, N. C. & Lindberg, U. The structure of crystalline profilin-β-actin. Nature 365, 810-816 (1993).
85. Van den Ent, F. & Lowe, J. Crystal structure of the cell division protein FtsA from Thermotoga maritima. EMBO J. 19, 5300-5307 (2000).
86. Osipiuk, J., Walsh, M. A., Freeman, B. C., Morimoto, R. I. & Joachimiak, A. Structure of a new crystal form of human Hsp70 ATPase domain. Acts Crystallogr. D 55, 1105-1107 (1999).
87. Obermann, W. M., Sondermann, H., Russo, A. A., Pavletich, N. P. & Hartl, F. U. In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis. J. Cell Biol. 143, 901-910 (1998).
88. Brino, L. et al. Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center. J. Biol. Chem. 275, 9468-9475 (2000).
89. Ban, C., Junop, M. & Yang, W. Transformation of MutL by ATP binding and hydrolysis: a switch in DNA mismatch repair. Cell 97, 85-97 (1999).
90. Berman, H. M. et al. The Protein Data Bank. Nucleic Acids Res. 28, 235-242 (2000).